Diabetes

Why We Care

Endocrinologists are often on the frontlines of the all-consuming, complex diabetes public health crisis. The Endocrine Society works to make a positive difference in the lives of patients with diabetes, and advocates for access to affordable care and diabetes supplies, and better funding for research focused on diabetes and its comorbidities. Learn more about this growing epidemic, its staggering costs, and who it disproportionately affects in the resources linked below. We also encourage interested members to join our new Diabetes Special Interest Group.

Advocacy Efforts

• Society launches campaign to Reauthorize the Special Diabetes Program (SDP) and support the INSULIN Act (October 2026): Advocacy is needed now because if Congress does not take action, SDP will expire December 31 and the INSULIN Act will have to wait until the next congressional term.
• Society Applauds Introduction of Bipartisan Bill to Address Insulin Affordability in the House (September 3, 2026): The Endocrine Society commends the introduction of the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act in the House of Representatives.
• Urge Your Representatives & Senators to Make Insulin More Affordable (current): We need Members of Congress to cosponsor and advance the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act in the Senate HELP Committee. LEARN MORE & TAKE ACTION

Position Statements and Guidance on Diabetes

• Preexisting Diabetes and Pregnancy (July 13, 2025): A joint guideline from the Endocrine Society and the European Society of Endocrinology (ESE) recommends women with diabetes receive proper preconception care and access to emerging diabetes technology and therapeutics to manage their blood sugar before, during and after pregnancy.
• Statement for the Record (December 2023): Senate HELP Committee hearing: "What is Fueling the Diabetes Epidemic?" 
• High Risk for Hypoglycemia Guideline Resources (December 2022): Clinical practice guideline addressing the fact that hypoglycemia is associated with distress in those with diabetes and their families, medication nonadherence, and disruption of life and work, and leads to costly emergency department visits and hospitalizations, morbidity, and mortality.
• Inpatient Hyperglycemia Guideline Resources (June 12, 2022): Clinical practice guideline that reflects evolving clinical science and provides evidence-based recommendations for clinical care and practice managing hyperglycemia in the inpatient setting.
• Increasing Insulin Affordability (January 2021): Society's position and recommendations on addressing insulin access and affordability. 

Resources

• Diabetes Research
• Diabetes Facts and Figures
• Diabetes Primer
• Special Diabetes Program Flyer
• Support the INSULIN Act in the Senate
• Support Comprehensive Insulin Affordability Legislation in the House

Recent Events

• Society launches Diabetes Special Interest Group (SIG) on October 19, 2026. New SIG provides a place for members to share knowledge, discuss emerging developments, and connect with colleagues working to advance diabetes science, prevention, and clinical care.
• The 13th Annual Endocrine Fellows Conference: Type 1 Diabetes Care and Management (June 2026): The annual event provides advanced support to endocrine fellows as they begin their careers as practicing clinicians and diabetes experts.
• Society Holds Diabetes Hill Day on Tuesday, March 5, 2024. Members met with Congressional staff to discuss the Society’s diabetes-related issues and policy priorities, including funding for the Special Diabetes Program (SDP).

Recent Society Letters

• Society Signs Joint Letter to Congress Expressing Concern With CMS Applying CBP to Continuous Glucose Monitors and Insulin Pumps (October 15, 2026): Society signs joint letter to Representatives expressing continued concern that CMS is applying the competitive bidding program (CBP) to continuous glucose monitors (CGMs) and insulin pumps, which will leave Medicare beneficiaries without access to these critical, lifesaving diabetes technologies.
• Congratulations Letter to Rep. Kim Schrier on Being Named Next Democratic Co-Chair of the Congressional Diabetes Caucus (October 01, 2026): Endocrine Society sends letter congratulating Rep. Kim Schrier on being named the next Democratic Co-Chair of the Congressional Diabetes Caucus.
• Society Leads Joint Letter Urging Senate HELP Committee to Pass INSULIN Act (June 10, 2026): The Endocrine Society lead on a joint letter to the Senate HELP Committee expressing concern about the high cost of insulin for people living with diabetes and urging the Committee to pass the INSULIN Act at its next legislative mark-up session.
• Friends of NIDDK FY 2027 Funding Recommendation (May 19, 2026): The Society led a coalition of medical school, patient, medical professional, and research organizations to submit a funding recommendation for the NIDDK for fiscal year 2027.
• Society Thanks Senate Sponsors of INSULIN Act of 2026 (March 25, 2026): Endocrine Society sends a thank you letter to the Senate sponsors of the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026.